These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15228394)
1. Management of chronic hepatitis C virus infection: a new era of disease control. Teoh NC; Farrell GC Intern Med J; 2004 Jun; 34(6):324-37. PubMed ID: 15228394 [TBL] [Abstract][Full Text] [Related]
2. Ribavirin in the treatment of hepatitis C. Abonyi ME; Lakatos PL Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084 [TBL] [Abstract][Full Text] [Related]
3. [Retreatment of patients with chronic hepatitis C]. Ostojić R Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242 [TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
5. Management of chronic hepatitis C. Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342 [TBL] [Abstract][Full Text] [Related]
7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933 [TBL] [Abstract][Full Text] [Related]
15. Treating hepatitis C infection in liver transplant recipients. Terrault NA; Berenguer M Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944 [TBL] [Abstract][Full Text] [Related]
16. Serine protease inhibitors as anti-hepatitis C virus agents. Reiser M; Timm J Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin. Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081 [TBL] [Abstract][Full Text] [Related]
18. Adverse effects of drugs in the treatment of viral hepatitis. Negro F Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):183-92. PubMed ID: 20227031 [TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis C and liver transplantation. Davis GL Rev Gastroenterol Disord; 2004; 4(1):7-17. PubMed ID: 15029106 [TBL] [Abstract][Full Text] [Related]
20. Management of hepatitis C: evaluating suitability for drug therapy. Ward RP; Kugelmas M; Libsch KD Am Fam Physician; 2004 Mar; 69(6):1429-36. PubMed ID: 15053407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]